Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Gerassimos J. Mantzaris, Anthie Gatopoulou et al.|Journal of Crohn s and Colitis|2021Cited by 148
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsElena Eliadou, Gionata Fiorino, Joana Moleiro et al.|Journal of Crohn s and Colitis|2019Cited by 44
P402 Interstitial and granulomatous lung disease in inflammatory bowel disease patientsElena Eliadou, Gionata Fiorino, J Moleiro et al.|Journal of Crohn s and Colitis|2018Cited by 3